Figure 3
From: Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancer
Pharmacokinetic analysis of erlotinib and its metabolite.
Figure 3 | British Journal of Cancer
From: Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancer
Pharmacokinetic analysis of erlotinib and its metabolite.
